Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2.

Schlacher K, Wu H, Jasin M.

Cancer Cell. 2012 Jul 10;22(1):106-16. doi: 10.1016/j.ccr.2012.05.015.

2.

CtIP mediates replication fork recovery in a FANCD2-regulated manner.

Yeo JE, Lee EH, Hendrickson EA, Sobeck A.

Hum Mol Genet. 2014 Jul 15;23(14):3695-705. doi: 10.1093/hmg/ddu078. Epub 2014 Feb 20.

3.

Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2.

Godthelp BC, Wiegant WW, Waisfisz Q, Medhurst AL, Arwert F, Joenje H, Zdzienicka MZ.

Mutat Res. 2006 Feb 22;594(1-2):39-48. Epub 2005 Sep 8.

PMID:
16154163
4.

Breast cancer and Fanconi anemia: what are the connections?

Zdzienicka MZ, Arwert F.

Trends Mol Med. 2002 Oct;8(10):458-60.

PMID:
12383764
5.

FANCD2, FANCJ and BRCA2 cooperate to promote replication fork recovery independently of the Fanconi Anemia core complex.

Raghunandan M, Chaudhury I, Kelich SL, Hanenberg H, Sobeck A.

Cell Cycle. 2015;14(3):342-53. doi: 10.4161/15384101.2014.987614.

6.

Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.

Hussain S, Witt E, Huber PA, Medhurst AL, Ashworth A, Mathew CG.

Hum Mol Genet. 2003 Oct 1;12(19):2503-10. Epub 2003 Aug 5.

PMID:
12915460
7.

Deletion of BRCA2 exon 27 causes defects in response to both stalled and collapsed replication forks.

Kim TM, Son MY, Dodds S, Hu L, Hasty P.

Mutat Res. 2014 Aug-Sep;766-767:66-72. doi: 10.1016/j.mrfmmm.2014.06.003. Epub 2014 Jun 22.

PMID:
25847274
8.

Deletion of BRCA2 exon 27 causes defects in response to both stalled and collapsed replication forks.

Kim TM, Son MY, Dodds S, Hu L, Hasty P.

Mutat Res. 2014 Aug-Sep;766-767:66-72. doi: 10.1016/j.mrfmmm.2014.06.003. Epub 2014 Jun 22.

9.
10.
11.

Exploring the link between MORF4L1 and risk of breast cancer.

Martrat G, Maxwell CM, Tominaga E, Porta-de-la-Riva M, Bonifaci N, Gómez-Baldó L, Bogliolo M, Lázaro C, Blanco I, Brunet J, Aguilar H, Fernández-Rodríguez J, Seal S, Renwick A, Rahman N, Kühl J, Neveling K, Schindler D, Ramírez MJ, Castellà M, Hernández G; EMBRACE., Easton DF, Peock S, Cook M, Oliver CT, Frost D, Platte R, Evans DG, Lalloo F, Eeles R, Izatt L, Chu C, Davidson R, Ong KR, Cook J, Douglas F, Hodgson S, Brewer C, Morrison PJ, Porteous M, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Roversi G, Barile M, Viel A, Pasini B, Ottini L, Putignano AL, Savarese A, Bernard L, Radice P, Healey S, Spurdle A, Chen X, Beesley J; kConFab., Rookus MA, Verhoef S, Tilanus-Linthorst MA, Vreeswijk MP, Asperen CJ, Bodmer D, Ausems MG, van Os TA, Blok MJ, Meijers-Heijboer HE, Hogervorst FB; HEBON., Goldgar DE, Buys S, John EM, Miron A, Southey M, Daly MB; BCFR.; SWE-BRCA., Harbst K, Borg A, Rantala J, Barbany-Bustinza G, Ehrencrona H, Stenmark-Askmalm M, Kaufman B, Laitman Y, Milgrom R, Friedman E, Domchek SM, Nathanson KL, Rebbeck TR, Johannsson OT, Couch FJ, Wang X, Fredericksen Z, Cuadras D, Moreno V, Pientka FK, Depping R, Caldés T, Osorio A, Benítez J, Bueren J, Heikkinen T, Nevanlinna H, Hamann U, Torres D, Caligo MA, Godwin AK, Imyanitov EN, Janavicius R; GEMO Study Collaborators., Sinilnikova OM, Stoppa-Lyonnet D, Mazoyer S, Verny-Pierre C, Castera L, de Pauw A, Bignon YJ, Uhrhammer N, Peyrat JP, Vennin P, Ferrer SF, Collonge-Rame MA, Mortemousque I, McGuffog L, Chenevix-Trench G, Pereira-Smith OM, Antoniou AC, Cerón J, Tominaga K, Surrallés J, Pujana MA.

Breast Cancer Res. 2011 Apr 5;13(2):R40. doi: 10.1186/bcr2862.

12.

Fanconi anemia: causes and consequences of genetic instability.

Kalb R, Neveling K, Nanda I, Schindler D, Hoehn H.

Genome Dyn. 2006;1:218-42. doi: 10.1159/000092510. Review.

PMID:
18724063
13.

siRNA depletion of BRCA1, but not BRCA2, causes increased genome instability in Fanconi anemia cells.

Bruun D, Folias A, Akkari Y, Cox Y, Olson S, Moses R.

DNA Repair (Amst). 2003 Sep 18;2(9):1007-13.

PMID:
12967657
14.

Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways.

Hussain S, Wilson JB, Medhurst AL, Hejna J, Witt E, Ananth S, Davies A, Masson JY, Moses R, West SC, de Winter JP, Ashworth A, Jones NJ, Mathew CG.

Hum Mol Genet. 2004 Jun 15;13(12):1241-8. Epub 2004 Apr 28.

PMID:
15115758
15.

Attenuation of the formation of DNA-repair foci containing RAD51 in Fanconi anaemia.

Digweed M, Rothe S, Demuth I, Scholz R, Schindler D, Stumm M, Grompe M, Jordan A, Sperling K.

Carcinogenesis. 2002 Jul;23(7):1121-6.

PMID:
12117768
16.

Therapeutic exploitation of tumor cell defects in homologous recombination.

Powell SN, Kachnic LA.

Anticancer Agents Med Chem. 2008 May;8(4):448-60. Review.

PMID:
18473729
17.

FANCD2 influences replication fork processes and genome stability in response to clustered DSBs.

Zhu J, Su F, Mukherjee S, Mori E, Hu B, Asaithamby A.

Cell Cycle. 2015;14(12):1809-22. doi: 10.1080/15384101.2015.1036210.

18.

Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2.

Hussain S, Wilson JB, Blom E, Thompson LH, Sung P, Gordon SM, Kupfer GM, Joenje H, Mathew CG, Jones NJ.

DNA Repair (Amst). 2006 May 10;5(5):629-40. Epub 2006 Apr 18.

PMID:
16621732
20.

Functional interplay between BRCA2/FancD1 and FancC in DNA repair.

Kitao H, Yamamoto K, Matsushita N, Ohzeki M, Ishiai M, Takata M.

J Biol Chem. 2006 Jul 28;281(30):21312-20. Epub 2006 May 10.

Supplemental Content

Support Center